Published in Genomics on February 10, 1995
Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys (1995) 8.87
Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem (1987) 4.99
Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature (1999) 4.32
Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol (1985) 3.63
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
Regulation of ribulose 1,5-bisphosphate carboxylase-oxygenase activities by temperature pretreatment and chloroplast metabolites. Arch Biochem Biophys (1976) 3.06
Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest (1999) 2.54
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys (1999) 2.47
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta (2000) 2.37
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature (1994) 2.37
Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem (1997) 2.35
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. Med Phys (1997) 2.05
Surgical pearl: suturing--control and conservation. J Am Acad Dermatol (1996) 2.05
How many nonmelanoma skin cancers require Mohs micrographic surgery? Dermatol Surg (1996) 1.98
A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci U S A (2005) 1.93
Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem (1996) 1.91
Molecular cloning of an allene oxide synthase: a cytochrome P450 specialized for the metabolism of fatty acid hydroperoxides. Proc Natl Acad Sci U S A (1993) 1.87
Progesterone and pregn-4-en-20 alpha-ol-3-one in ovarian venous blood during various reproductive states in the rat. Endocrinology (1968) 1.80
Artemia salina as a Test Organism for Bioassay. Science (1956) 1.80
Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet (1994) 1.76
Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther (1994) 1.75
Intracellular binding and transport of hormones and xenobiotics by glutathione-S-transferases. Drug Metab Rev (1988) 1.62
Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem (1995) 1.61
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem (1993) 1.59
Accumulation of acyl-enzyme in DD-peptidase-catalysed reactions with analogues of peptide substrates. Biochem J (1991) 1.58
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys (1991) 1.58
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol (1997) 1.56
Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol (1994) 1.49
A distinct human testis and brain mu-class glutathione S-transferase. Molecular cloning and characterization of a form present even in individuals lacking hepatic type mu isoenzymes. J Biol Chem (1990) 1.48
Serine-type D-Ala-D-Ala peptidases and penicillin-binding proteins. Methods Enzymol (1994) 1.46
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation (2001) 1.46
Molecular cloning and amino acid sequence of human 5-lipoxygenase. Proc Natl Acad Sci U S A (1988) 1.45
12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation (2001) 1.45
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci U S A (1999) 1.42
Ascending aorta-to-coronary artery saphenous vein bypass grafts. J Thorac Cardiovasc Surg (1970) 1.41
A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther (2007) 1.40
Receptor for motilin identified in the human gastrointestinal system. Science (1999) 1.39
Analysis of factors affecting the therapeutic gain in high dose rate gynecological implants relative to low dose rate implants. Med Phys (1996) 1.38
Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer (1982) 1.35
5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett (1993) 1.35
cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem (1994) 1.32
Enzymes involved in the biosynthesis of leukotriene B4. J Biol Chem (1989) 1.32
Studies on the chemical nature of elastin fluorescence. Biochim Biophys Acta (1980) 1.31
Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest (1999) 1.30
Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci U S A (1998) 1.29
Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. J Biol Chem (1994) 1.28
Selective expression of a unique glutathione S-transferase Yb3 gene in rat brain. J Biol Chem (1987) 1.27
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci U S A (2001) 1.26
Engineering and overexpression of periplasmic forms of the penicillin-binding protein 3 of Escherichia coli. Biochem J (1994) 1.23
A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture. Anal Biochem (2000) 1.21
5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am J Physiol (1997) 1.20
Emergency myocardial revascularization for impending infarctions and arrhythmias. J Thorac Cardiovasc Surg (1971) 1.13
Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase. Proc Natl Acad Sci U S A (1998) 1.13
Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg (1997) 1.13
DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. Neoplasia (1999) 1.12
The N-terminal "beta-barrel" domain of 5-lipoxygenase is essential for nuclear membrane translocation. J Biol Chem (2001) 1.10
Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem (1994) 1.09
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br J Pharmacol (1998) 1.08
12/15-lipoxygenase translocation enhances site-specific actin polymerization in macrophages phagocytosing apoptotic cells. J Biol Chem (2001) 1.08
The fate of the transferrin receptor during maturation of sheep reticulocytes in vitro. Can J Biochem Cell Biol (1984) 1.06
The nucleotide sequence of a voltage-gated chloride channel from the electric organ of Torpedo californica. Biochim Biophys Acta (1991) 1.06
Characterization of a novel serotonin receptor from Caenorhabditis elegans: cloning and expression of two splice variants. J Neurochem (1999) 1.06
Oral administration of (14)C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J Nutr (1999) 1.04
Interactions between an HMG-1 protein and members of the Rel family. Proc Natl Acad Sci U S A (1999) 1.04
Activation of transcription in vitro by recruitment of the yeast RNA polymerase II holoenzyme. Mol Cell (1998) 1.04
A study of the distribution of methotrexate in human tissues and tumors. Cancer Res (1970) 1.04
Transcriptional activation by artificial recruitment in mammalian cells. Proc Natl Acad Sci U S A (1999) 1.03
Hyperinfection syndrome with Strongyloides stercoralis in malignant lymphoma. Br Med J (1973) 1.03
Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts. Br J Cancer (2010) 1.03
Conformational changes associated with the reversible cold inactivation of ribulose-1,5-bisphosphate carboxylase-oxygenase. Biochim Biophys Acta (1977) 1.03
Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem (1998) 1.03
A "natural" volume-dose histogram for brachytherapy. Med Phys (1987) 1.02
Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis. Am J Physiol (1994) 1.02
The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2000) 1.00
Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts. Leukemia (2002) 1.00
cDNA cloning, expression, mutagenesis, intracellular localization, and gene chromosomal assignment of mouse 5-lipoxygenase. J Biol Chem (1995) 0.99
Experimental and Monte Carlo dosimetry of the Henschke applicator for high dose-rate 192Ir remote afterloading. Med Phys (1998) 0.99
Glutathione-S-transferases are major cytosolic thyroid hormone binding proteins. Arch Biochem Biophys (1989) 0.99
Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains. J Biol Chem (1994) 0.98
Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production. J Leukoc Biol (1998) 0.98
The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem (2001) 0.98
Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Int J Radiat Oncol Biol Phys (1989) 0.98
The leukergy test in rheumatic diseases. New implications for an old test. Arthritis Rheum (1985) 0.98
Reaction of gold with collagen in vivo. Experientia (1964) 0.97
Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells. J Biol Chem (1999) 0.97
Determinants of 5-lipoxygenase nuclear localization using green fluorescent protein/5-lipoxygenase fusion proteins. J Biol Chem (1998) 0.96
Emergency myocardial revascularization for impending myocardial infarctions. Chest (1972) 0.96
Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. Mol Pharmacol (2001) 0.96
Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett (1994) 0.96
Pregnancy rates per artificial insemination for cows and heifers inseminated at a synchronized ovulation or synchronized estrus. J Dairy Sci (1997) 0.96
Biomechanical and biological properties of the implant material carbon-carbon composite covered with pyrolytic carbon. J Mater Sci Mater Med (2000) 0.96
Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP). J Biol Chem (1991) 0.95
Cyanate modification of essential lysyl residues in the catalytic subunit of tobacco ribulosebisphosphate carboxylase. Biochim Biophys Acta (1978) 0.95
Purification and characterization of recombinant histidine-tagged human platelet 12-lipoxygenase expressed in a baculovirus/insect cell system. Eur J Biochem (1993) 0.95
Biological and biochemical properties of the carbon composite and polyethylene implant materials. J Mater Sci Mater Med (2003) 0.94
Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies. Neuropathol Appl Neurobiol (2000) 0.94